Medication info

SD1-2 weeks

Prescription medicationIntravenous injection
Ingredient · strength
Glucose›33.3g / 1000mLSodium Chloride›3g / 1000mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
A colorless, transparent liquid contained in a polypropylene, multi-layer film plastic container
Packaging
500mL/bag
Approval status
Active

MFDS item code 197000016 · Notified 1970.10.30 · Insurance code 644901481

Summary

Main use
Replenishment of fluids and electrolytes in dehydration and before and after surgery; improvement of energy supply
Who receives it
Adults · Children
Adult administration
The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.
Child administration
For children, administer at a rate of 50~100mL per hour. Do not administer rapidly (at a rate of 100mL or more per hour), especially to newborns and premature infants.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Replenishment of fluids and electrolytes in dehydration and before and after surgery; improvement of energy supply

  • Dehydration
View approved original text

This medication helps replenish fluids and electrolytes needed for dehydration or before and after surgery, while also aiding in the supply of energy in the body. Therefore, it is effective for improving dehydration symptoms and recovering physical strength, and it is used to stabilize overall health.

How it is given

Adult administration

The usual dose for adults is 500~1,000mL per dose by intravenous drip infusion. The infusion rate is 300~500mL per hour (75~120 drops per minute). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Child administration

For children, administer at a rate of 50~100mL per hour. Do not administer rapidly (at a rate of 100mL or more per hour), especially to newborns and premature infants.

Precautions

Caution is required as this medication may lead to a rapid depletion of vitamin B1 (thiamine) in patients receiving intravenous glucose-containing solutions, resulting in severe deficiency. This medication should not be administered to patients with excessive fluid volume or storage-type dehydration, or to patients with low serum potassium levels. It should be used cautiously in patients with impaired renal function, heart failure, those with hyperosmolar dehydration (elevated blood concentration), patients with reduced urine output due to urinary obstruction, diabetic patients, and those with high serum chloride levels. Administering this medication at a rapid rate or in large volumes can lead to brain and lung edema, as well as body swelling and acidosis; there is a particular risk of fluid overload in newborns and premature infants. Care should also be taken as there is a potential risk of thrombosis at the intravenous injection site. During treatment, blood glucose levels, blood electrolyte balance, and fluid status should be regularly monitored for any abnormalities. The container of this medication is made of PVC material containing the plasticizer DEHP, which may affect reproductive development in animal studies, but the actual risk to humans is considered very low and does not necessitate avoidance of its use. The safety of this medication during pregnancy has not been fully established, and it should only be used after careful consideration of the risks to the fetus and the benefits of treatment. Caution is advised when administering during labor, as both mother and fetus may experience metabolic disturbances such as hyperglycemia or hypoglycemia. Newborns, particularly premature or low birth weight infants, have difficulty controlling blood glucose levels, which increases the risk of hypoglycemia or hyperglycemia, necessitating careful monitoring of blood glucose levels. Rapid or prolonged administration should be avoided in infants and the elderly, and in elderly patients with heart failure or renal failure, it should be administered more cautiously to reduce cardiovascular burden. In cases of overdose, treatment with diuretics may be necessary to manage body fluid levels. Before administration, the patient's skin and injection equipment should be thoroughly disinfected to prevent infections, and particularly in cold seasons, the medication should be warmed to body temperature before use. Opened medication should be used immediately, and any remaining solution should not be reused. When injecting, it should be done slowly intravenously, and to reduce the risk of air embolism, the containers should not be connected in series. Lastly, this medication should be stored at room temperature, and proper storage and handling are essential.

Side effects

  • cerebral edema
  • pulmonary edema
  • peripheral edema
  • acidosis
  • water intoxication
  • thrombosis
  • hyperglycemia
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. This helps maintain the medication's efficacy and prevents degradation.

Appearance and packaging

Appearance

A colorless, transparent liquid contained in a polypropylene, multi-layer film plastic container

Package unit

500mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.